Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)

NCT02687594 · clinicaltrials.gov ↗

COMPLETED

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: sucroferric oxyhydroxide

Sponsor

Vifor Fresenius Medical Care Renal Pharma